SCHEMBL29664269

SCHEMBL29664269

Nc1cccc(-c2cnn(-c3cccs3)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.48
ATAD2 Q6PL18 1/20 0.42
MAP4K4 O95819 5/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MEN1 O00255 1/20 0.41
PSIP1 O75475 1/20 0.41
AXL P30530 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
MAOA P21397 1/20 0.40
FYN P06241 1/20 0.37
TSHR P16473 1/20 0.36
RECQL P46063 1/20 0.36
CYP17A1 P05093 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
GRM5 P41594 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16040316 0.82 GRM4 (0.58) GRM4LMNATP53MEN1TSHR
SCHEMBL23144521 0.77 MKNK1 (0.50) GRM4MAP4K4MEN1PSIP1AXL
SCHEMBL29664328 0.77 MKNK1 (0.50) GRM4MAP4K4MEN1PSIP1AXL
SCHEMBL23144535 0.76 MAOA (0.53) GRM4MAP4K4LMNAMEN1PSIP1
SCHEMBL29664332 0.76 MAOA (0.53) GRM4MAP4K4LMNAMEN1PSIP1
SCHEMBL16039629 0.75 GRM4 (0.51) GRM4MAP4K4TP53
SCHEMBL23144559 0.74 MAOA (0.55) MAP4K4LMNAMEN1PSIP1AXL
SCHEMBL23144544 0.72 GRM4 (0.47) GRM4MAP4K4MEN1PSIP1AXL
SCHEMBL23144576 0.72 MAP4K4 (0.44) GRM4MAP4K4TP53MEN1PSIP1
SCHEMBL29664194 0.72 MAP4K4 (0.44) GRM4MAP4K4TP53MEN1PSIP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728909-A Composition for preventing or treating cancer comprising novel trifluoromethylphenylpyrazole derivative as active ingredient 韩国原子力医学院 2022-07-08 CN disclosed